emodin has been researched along with ellagic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, X; Shao, L; Wang, S; Zhang, H | 1 |
| Hirasawa, A; Kinoshita, T; Kitaura, K; Nakanishi, I; Nakaniwa, T; Sekiguchi, Y; Tada, T; Tsujimoto, G | 1 |
| Bednarski, P; Götz, C; Hemmerling, HJ; Hundsdörfer, C; Jose, J; Le Borgne, M; Totzke, F | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Alvarez, L; Baratin, S; Bollacke, A; Desplat, V; Guillon, J; Jose, J; Le Borgne, M; Marchivie, M; Moreau, S; Pecci, A; Pinaud, N; Rimbault, C; Roche, S; Savrimoutou, S | 1 |
| Aichele, D; Bollacke, A; Bouaziz, Z; Cadena, SM; Daflon-Yunes, N; Di Pietro, A; Guillon, J; Jabor Gozzi, G; Jose, J; Lacoudre, A; Le Borgne, M; Marminon, C; Nacereddine, A; Pinaud, N; Valdameri, G; Winter, E; Zeinyeh, W | 1 |
| Chen, T; Chen, Y; Feng, F; Guo, Q; Lin, H; Liu, W; Liu, Z; Qiao, Y; Qu, W; Sun, H; Yang, H | 1 |
| Christy, MP; Gerwick, L; Gerwick, WH; Uekusa, Y | 1 |
2 review(s) available for emodin and ellagic acid
| Article | Year |
|---|---|
Small molecule modulators targeting protein kinase CK1 and CK2.
Topics: Animals; Casein Kinase I; Casein Kinase II; Drug Discovery; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Small Molecule Libraries | 2019 |
Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.
Topics: Animals; Antiviral Agents; Biological Products; COVID-19 Drug Treatment; Drug Development; Genome, Viral; Humans; RNA Virus Infections; RNA Viruses; Virus Replication | 2021 |
6 other study(ies) available for emodin and ellagic acid
| Article | Year |
|---|---|
CHMIS-C: a comprehensive herbal medicine information system for cancer.
Topics: Antineoplastic Agents, Phytogenic; Databases, Factual; Internet; National Institutes of Health (U.S.); Neoplasms; Phytotherapy; Plant Preparations; United States; United States Food and Drug Administration | 2005 |
Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Topics: Adenosine Triphosphate; Binding Sites; Casein Kinase II; Catalytic Domain; Crystallography, X-Ray; Ellagic Acid; Enzyme Inhibitors; Humans; Protein Structure, Tertiary | 2009 |
Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.
Topics: Casein Kinase II; Cell Membrane Permeability; Humans; Indoles; Kinetics; Protein Kinase Inhibitors; Stereoisomerism | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.
Topics: Casein Kinase II; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrroles; Quinoxalines; Structure-Activity Relationship | 2013 |
Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Casein Kinase II; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; HEK293 Cells; Humans; Indoles; MCF-7 Cells; Mitoxantrone; Models, Chemical; Molecular Structure; Neoplasm Proteins; Protein Kinase Inhibitors | 2015 |